Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOTHIEPIN vs DOXORUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOTHIEPIN vs DOXORUBICIN: Safety Overview

Metric DOTHIEPIN DOXORUBICIN
Total FAERS Reports 260 82,754
Deaths Reported 37 15,653
Death Rate 14.2% 18.9%
Hospitalizations 96 28,630
Average Patient Age 35.5 yrs 50.5 yrs
% Female Patients 17.8% 53.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued